This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carr, B. I. Search for Related Content PubMed PubMed Citation Articles by Carr, B. I.

Pleiotropic Drug Resistance in Hepatocytes Induced by Carcinogens Administered to Rats¹

Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, California 91010

The effect of hepatocarcinogen administration in vivo on the induction of pleiotropic drug resistance was studied in primary monolayer cultures of adult rat hepatocytes using a cytotoxicity assay in vitro. Dietary 2-acetylaminofluorene, 3'-methyl-4-dimethylaminoazobenzene, aflatoxin B₁, ethionine, and diethylnitrosamine rapidly induced resistance to doses of Adriamycin, methotrexate, cycloheximide, and aflatoxin B₁ which were cytocidal to normal hepatocytes from untreated rats. Up to 95% of some hepatocyte preparations became drug resistant before any new hepatocyte phenotypes could proliferate. Drug resistance was measured at 24 h after initiation of 2-acetylaminofluorene feeding and remained stable throughout the 16 wk of carcinogen exposure. When limited carcinogen exposure was followed by a return to a basal non-carcinogen-containing diet for many months, the hepatocytes in the resultant hepatocellular carcinomas also displayed pleiotropic drug resistance, and the cells of the peritumorous liver did so to a lesser extent. Drug resistance was not induced by chronic administration of the tumor promoters phenobarbital, cholinedeficient diet, phorbol, nor with 2,3,7,8-tetrachlorodibenzo-p-dioxin, but was induced to a variable extent by three hepatotoxins (ethanol, methotrexate, carbon tetrachloride). Whereas the early appearing drug resistance appears to be an adaptation of the liver to the presence of a toxic carcinogen, the late resistance which does not disappear after withdrawal of the inducing carcinogen may be a constitutive characteristic of chemically induced hepatocellular carcinomas.

¹ Some of these data have been presented in preliminary form (64).

² To whom requests for reprints should be addressed, at Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, 1500 E. Duarte Rd., Duarte, CA 91010.

Received 7/14/86. Revised 6/22/87. Accepted 8/ 7/87.

This article has been cited by other articles:

				P.-C. Klohn, M. E. Soriano, W. Irwin, D. Penzo, L. Scorrano, A. Bitsch, H.-G. Neumann, and P. Bernardi Early resistance to cell death and to onset of the mitochondrial permeability transition during hepatocarcinogenesis with 2-acetylaminofluorene PNAS, August 19, 2003; 100(17): 10014 - 10019. [Abstract] [Full Text] [PDF]

				R. Kessler, M.-F. Hamou, M. Albertoni, N. de Tribolet, M. Arand, and E. G. Van Meir Identification of the Putative Brain Tumor Antigen BF7/GE2 as the (De)Toxifying Enzyme Microsomal Epoxide Hydrolase Cancer Res., March 1, 2000; 60(5): 1403 - 1409. [Abstract] [Full Text]

				G. Zhou and M. T. Kuo Wild-type p53-mediated Induction of Rat mdr1b Expression by the Anticancer Drug Daunorubicin J. Biol. Chem., June 19, 1998; 273(25): 15387 - 15394. [Abstract] [Full Text] [PDF]